Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Alessandra N L Prezotti, Paula Ribeiro Villaça, Debora M C Rocha, Maria P S V Orletti, Christiane Lourenço, Gabriela G Yamaguti Hayakawa, Margareth C Ozelo

Blood (2022) 140 (Supplement 1): 57–58.

https://doi.org/10.1182/blood-2022-171028

Published: 2022

Journal Articles

Extracellular Vesicles As Markers of Inflammation and Hypercoagulability during the First Month of Sars-COV-2 Infection in Outpatients and Hospitalized Patients

Bárbara Gomes Barion, Tania Rubia Rocha, Ho Yeh-Li, Paula Ribeiro Villaça, Bruna M Mazetto, Erica Okasaki, Bianca Stefanello, Cynthia Rothschild, Vanderson Gomes Rocha, Fernanda Andrade Orsi

Blood (2022) 140 (Supplement 1): 8378–8379.

https://doi.org/10.1182/blood-2022-168977

Published: 2022

Journal Articles

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Alessandra N L Prezotti, MD MSc, Monica H Cerqueira, MD PhD, Marilia Renni, MD MSc, Clarissa Ferreira, MD, Ieda S. Pinto, MD, Maria do Rosário Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaça, MD PhD, Maria P S V Orletti, Carolina Costa-Lima, MD MSc, Gabriela G Yamaguti-Hayakawa, MD, Samuel S Medina, MD MSc, Margareth C Ozelo, MD PhD

Blood (2018) 132 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2018-99-119754

Published: 2018

Journal Articles

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Alessandra N L Prezotti, MD, Clarissa Ferreira, MD, Luciana Oliveira, MD PhD, Claudia Lorenzato, MD PhD, Maria P S V Orletti, Maria do Rosario Roberti, MD PhD, Rosangela Ribeiro, MD, Paula Ribeiro Villaca, MD PhD, Silmara Aparecida De Lima Montalvão, Samuel S Medina, MD, Gabriela G Yamaguti Hayakawa, MD, Margareth C Ozelo, MD PhD

Blood (2017) 130 (Supplement 1): 2357.

https://doi.org/10.1182/blood.V130.Suppl_1.2357.2357

Published: 2017

Journal Articles

Thrombin Generation in Paroxysmal Nocturnal Haemoglobinuria

Audrey Krüse Zeinad, MD PhD, Tania RFR Rocha, Pharmacist, Sandra Fatima Menosi Guallandro, MD PhD, Guilherme Henrique Hencklain Fonseca, MD, Paula Ribeiro Villaça, MD PhD, Erica Okazaki, MD, Vanderson Rocha, MD PhD, Elbio Antonio D'Amico, MD PhD

Blood (2016) 128 (22): 1426.

https://doi.org/10.1182/blood.V128.22.1426.1426

Published: 2016

Journal Articles

Immune Tolerance Induction Treatment Is Cost-Effective in Adult Patients with Long-Standing High-Responding Inhibitors

Alessandra Nunes Loureiro Prezotti, MD, Silmara Aparecida De Lima Montalvão, MSc, Cláudia Lorenzato, MD, Andrea Maia Oliveira, MD, Maria do Perpétuo Socorro Vendramini Orletti, Maria Do Rosario Ferraz Roberti, MD, Luiz Ivando Ferreira Filho, MD, Paula Ribeiro Villaça, MD PhD, Erica Okazaki, MD, Samuel de Souza Medina, MD, Margareth Castro Ozelo, MD PhD

Blood (2015) 126 (23): 3530.

https://doi.org/10.1182/blood.V126.23.3530.3530

Published: 2015

NARROW

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Extracellular Vesicles As Markers of Inflammation and Hypercoagulability during the First Month of Sars-COV-2 Infection in Outpatients and Hospitalized Patients

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Thrombin Generation in Paroxysmal Nocturnal Haemoglobinuria

Immune Tolerance Induction Treatment Is Cost-Effective in Adult Patients with Long-Standing High-Responding Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Incidence of Inhibitors in Previously Untreated Patients with Severe Hemophilia a Treated with Plasma-Derived Vs. Recombinant Factor VIII Concentrates: A Systematic Review and Meta-Analyses

Extracellular Vesicles As Markers of Inflammation and Hypercoagulability during the First Month of Sars-COV-2 Infection in Outpatients and Hospitalized Patients

Incidence of Inhibitors in a Previously Untreated Patients with Severe Hemophilia Α Cohort Treated with a Single Third-Generation Recombinant Factor VIII Concentrate

Evaluation of Predictors of Outcome in Immune Tolerance Induction Treatment of Hemophilia Α Patients with High-Responding Inhibitors

Thrombin Generation in Paroxysmal Nocturnal Haemoglobinuria

Immune Tolerance Induction Treatment Is Cost-Effective in Adult Patients with Long-Standing High-Responding Inhibitors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only